[1]
Gotesman, R. 2018. Antisense Oligonucleotide Gene Therapy for Neuromuscular Disorders. University of Ottawa Journal of Medicine. 8, 2 (Nov. 2018), 11–14. DOI:https://doi.org/10.18192/uojm.v8i2.3462.